Bausch Health Companies Inc. Decrease in Unrecognized Tax Benefits is Reasonably Possible
Bausch Health Companies Inc. (BHC) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $9.00 million as of 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2025-02-20
- 2024-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $9.00M.
- 2024-09-30: Decrease in Unrecognized Tax Benefits is Reasonably Possible $29.00M.
- 2024-06-30: Decrease in Unrecognized Tax Benefits is Reasonably Possible $27.00M.
- 2024-03-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $30.00M.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible | Decrease in Unrecognized Tax Benefits is Reasonably Possible as first filed |
|---|---|---|
| 2024-12-31 | $9.00M 10-K · filed 2025-02-20 | |
| 2024-09-30 | $29.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $27.00M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $30.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $30.00M 10-K · filed 2024-02-22 | |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $4.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $4.00M 10-K · filed 2023-02-23 | |
| 2022-09-30 | $13.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $14.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $21.00M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $104.00M 8-K · filed 2022-05-11 | |
| 2021-09-30 | $194.00M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $198.00M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $203.00M 10-Q · filed 2021-05-04 | |
| 2020-09-30 | $141.00M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $136.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $110.00M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $145.00M 8-K · filed 2021-05-04 | $110.00M 10-K · filed 2020-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |